Ironwood Pharmaceuticals | IRWD - Current Liabilities


Ironwood Pharmaceuticals reported $242.5M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Acadia Pharmaceuticals USD 356.58M 26.56M Sep/2025
Agios Pharmaceuticals USD 74.76M 4.35M Sep/2025
Almirall EUR 298.52M 54.91M Jun/2025
Alnylam Pharmaceuticals USD 1.56B 254.63M Sep/2025
Amarin USD 182.23M 3.71M Sep/2025
Ardelyx USD 83.39M 1.67M Sep/2025
Astellas Pharma JPY 1.33T 217.52B Sep/2025
AstraZeneca USD 34.05B 518M Sep/2025
Charles River Laboratories USD 1.12B 41.45M Sep/2025
Exact Sciences USD 584.26M 62.33M Sep/2025
Halozyme Therapeutics USD 837.23M 702.95M Sep/2025
Incyte USD 1.34B 60.11M Sep/2025
Ironwood Pharmaceuticals USD 242.5M 9.98M Sep/2025
MacroGenics USD 44.47M 5.47M Sep/2025
Moderna USD 1.68B 109M Sep/2025
Myriad Genetics USD 148M 51.9M Sep/2025
Pacira USD 107.08M 206.09M Sep/2025
PTC Therapeutics USD 866.24M 238.44M Sep/2025
Sarepta Therapeutics USD 921.42M 1.48M Sep/2025
Takeda JPY 2.61T 470.53B Dec/2025
Ultragenyx Pharmaceutical USD 340.02M 46.78M Sep/2025